We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$6.11B
AUM Growth
+$186M
Cap. Flow
-$115M
Cap. Flow %
-1.89%
Top 10 Hldgs %
13.08%
Holding
303
New
11
Increased
95
Reduced
181
Closed
15

Sector Composition

Rank Sector Weight
1 Industrials 16.06%
2 Technology 16%
3 Healthcare 13.61%
4 Financials 13.09%
5 Consumer Discretionary 11.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPLN
26
Openlane
OPLN
$4.58B
$50M 0.82%
2,408,775
-75,410
-3% -$1.54M
AVNT icon
27
Avient
AVNT
$4.19B
$49.1M 0.8%
1,136,607
+116,371
+11% +$5M
MDSO
28
DELISTED
Medidata Solutions, Inc.
MDSO
$47.2M 0.77%
585,307
-4,602
-0.8% -$345K
AMT icon
29
American Tower
AMT
$78.8B
$47M 0.77%
326,071
-8,523
-3% -$1.18M
TXRH icon
30
Texas Roadhouse
TXRH
$13.6B
$45.9M 0.75%
700,216
-120,075
-15% -$7.53M
ABCB icon
31
Ameris Bancorp
ABCB
$5.88B
$45.6M 0.75%
854,011
-7,428
-0.9% -$406K
MKTX icon
32
MarketAxess Holdings
MKTX
$5.72B
$45.5M 0.75%
230,125
-5,784
-2% -$1.2M
COTV
33
DELISTED
Cotiviti Holdings, Inc.
COTV
$45.4M 0.74%
1,028,619
+151,738
+17% +$5.51M
LMT icon
34
Lockheed Martin
LMT
$139B
$45M 0.74%
152,396
-4,839
-3% -$1.56M
SYNH
35
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$44.8M 0.73%
954,813
+201,889
+27% +$8.36M
PFGC icon
36
Performance Food Group
PFGC
$17.9B
$44.1M 0.72%
1,201,803
-7,329
-0.6% -$248K
ZBRA icon
37
Zebra Technologies
ZBRA
$17.9B
$43.4M 0.71%
303,168
-78,063
-20% -$11.5M
ABBV icon
38
AbbVie
ABBV
$438B
$42.7M 0.7%
460,381
-14,476
-3% -$1.41M
CSGP icon
39
CoStar Group
CSGP
$12.8B
$42.4M 0.69%
1,028,050
-15,720
-2% -$605K
SIVB
40
DELISTED
SVB Financial Group
SIVB
$41.5M 0.68%
143,762
-38,800
-21% -$11.4M
RPM icon
41
RPM International
RPM
$14.8B
$41.3M 0.68%
708,708
-15,969
-2% -$801K
CVA
42
DELISTED
Covanta Holding Corporation
CVA
$39.2M 0.64%
2,375,211
+265,997
+13% +$4.19M
AMGN icon
43
Amgen
AMGN
$226B
$38.9M 0.64%
210,537
-6,092
-3% -$1.08M
GSK icon
44
GSK
GSK
$104B
$38.4M 0.63%
762,822
-21,392
-3% -$1.08M
HCSG icon
45
Healthcare Services Group
HCSG
$1.5B
$38.3M 0.63%
886,357
-1,753
-0.2% -$69.6K
ANSS
46
DELISTED
Ansys
ANSS
$38.1M 0.62%
218,859
-4,267
-2% -$710K
BCPC
47
Balchem Corp
BCPC
$5.65B
$37.4M 0.61%
381,255
-2,861
-0.7% -$267K
AVGO icon
48
Broadcom
AVGO
$2.01T
$36M 0.59%
1,483,500
+53,420
+4% +$1.31M
INTC icon
49
Intel
INTC
$492B
$35.4M 0.58%
711,229
-131,360
-16% -$6.98M
EDR
50
DELISTED
Education Realty Trust Inc
EDR
$35.3M 0.58%
850,196
-4,473
-0.5% -$159K

Similar funds

GW&K Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, GW&K Investment Management held 303 positions worth $6.11B, up 3.1% from $5.92B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management's Q2 2018 filing shows 11 new, 95 increased, 181 reduced and 15 closed positions. Its largest new stake was Amneal Pharmaceuticals: 1,956,906 shares worth $32.1M. The largest sale was Tyler Technologies, an estimated $48M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q2 2018 buy was Amneal Pharmaceuticals: 1,956,906 shares worth $32.1M.
  • GW&K Investment Management added most to Pacific Premier Bancorp in Q2 2018, an estimated $17.9M increase.
  • GW&K Investment Management's biggest Q2 2018 reduction was Tyler Technologies, cutting an estimated $48M.
  • GW&K Investment Management fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $38.5M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $6.11B portfolio in Q2 2018.
  • GW&K Investment Management opened 11 new positions and closed 15 in Q2 2018.
  • GW&K Investment Management's portfolio value rose 3.1% quarter-over-quarter to $6.11B.

Based on GW&K Investment Management's 13F filing for Q2 2018, filed 7 Aug 2018.